Stock Events

Stock Events

Evofem Biosciences 

$0.008800
135
+$0.00+25.71% Wednesday 19:56

Statistics

Day High
0.0088
Day Low
0.0075
52W High
0.02
52W Low
0.001
Volume
385,634
Avg. Volume
-
Mkt Cap
1.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.04
-0.03
-0.03
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-46.3%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
38.73MRevenue
-17.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVFM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.38B
Pfizer offers a range of contraceptives and women's health products, directly competing with Evofem's contraceptive solutions.
Merck
MRK
Mkt Cap294.03B
Merck produces various contraceptives and women's health products, making it a direct competitor to Evofem Biosciences.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries offers generic and specialty medicines, including contraceptives, competing in the same space as Evofem.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its pharmaceutical division, offers products in women's health, including contraceptives, competing with Evofem.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, having acquired Allergan, competes in the women's health and contraceptives market, overlapping with Evofem's offerings.
Lilly(Eli) &
LLY
Mkt Cap1.01T
Eli Lilly, while primarily focused on other areas, has interests in women's health that could position it as a competitor to Evofem.
Novo Nordisk
NVO
Mkt Cap194.35B
Novo Nordisk, with its focus on chronic diseases, has shown interest in expanding into women's health, potentially competing with Evofem.
AMGEN
AMGN
Mkt Cap191.7B
Amgen, primarily known for biopharmaceuticals, has the potential to enter the women's health market, posing a future competitive threat to Evofem.

About

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Show more...
CEO
Ms. Saundra Pelletier
Employees
32
Country
United States
ISIN
US30048L3024

Listings

OTC Link
US
EVFM

0 Comments

Share your thoughts

FAQ

What is Evofem Biosciences stock price today?▼
The current price of EVFM is $0.01 USD — it has increased by +25.71% in the past 24 hours. Watch Evofem Biosciences stock price performance more closely on the chart.
What is Evofem Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Evofem Biosciences stocks are traded under the ticker EVFM.
Is Evofem Biosciences stock price growing?▼
EVFM stock has risen by +17.33% compared to the previous week, the month change is a +39.68% rise, over the last year Evofem Biosciences has showed a -8.33% decrease.
What is Evofem Biosciences market cap?▼
Today Evofem Biosciences has the market capitalization of 1.11M
When is the next Evofem Biosciences earnings date?▼
Evofem Biosciences is going to release the next earnings report on August 19, 2026.
What were Evofem Biosciences earnings last quarter?▼
EVFM earnings for the last quarter are -0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Evofem Biosciences revenue for the last year?▼
Evofem Biosciences revenue for the last year amounts to 38.73M USD.
What is Evofem Biosciences net income for the last year?▼
EVFM net income for the last year is -17.93M USD.
How many employees does Evofem Biosciences have?▼
As of June 18, 2026, the company has 32 employees.
In which sector is Evofem Biosciences located?▼
Evofem Biosciences operates in the Health & Wellness sector.
When did Evofem Biosciences complete a stock split?▼
The last stock split for Evofem Biosciences was on May 18, 2023 with a ratio of 1:125.
Where is Evofem Biosciences headquartered?▼
Evofem Biosciences is headquartered in San Diego, United States.